A Phase I Study of Pyrimethamine in Patients With GM2 Gangliosidosis

Clinical trial NCT00679744 · WITHDRAWN

Trial details

NCT number: NCT00679744
Sponsor: Exsar Corporation
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

G(M2) Ganglioside Tay-Sachs Disease Ganglioside Sandhoff Disease Ganglioside

Start date: 2008-05-01
Primary completion: 2010-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.